Talaris Therapeutics Inc. Recorded Big Gain
Tue, May 17, 2022 at 05:34 PM
Talaris Therapeutics Inc. (TALS:NASDAQ) soared at $8.89, a gain of 35.9%. On Mon, May 16, 2022, TALS:NASDAQ touched a New 2-Week Intraday Low of $5.7. The stock appeared on our News Catalysts scanner on Tue, May 17, 2022 at 05:07 PM in the 'MISCELLANEOUS' category. From Tue, May 03, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
About Talaris Therapeutics Inc. (TALS:NASDAQ)
Talaris Therapeutics Inc is a late-clinical stage biotechnology company.
Top 10 Gainers:
- Eos Energy Enterprises Inc. (EOSE:NASDAQ), 41.79%
- FlexShopper, Inc. (FPAY:NASDAQ), 36.88%
- Talaris Therapeutics Inc. (TALS:NASDAQ), 35.93%
- Mmtec, Inc. (MTC:NASDAQ), 35.78%
- Redbox Entertainment Inc. (RDBX:NASDAQ), 35.76%
- Enthusiast Gaming Holdings Inc. (EGLX:NASDAQ), 35.16%
- Biomea Fusion Inc. (BMEA:NASDAQ), 34.54%
- NiSun Intl Enterprise Development Group Co Ltd (NISN:NASDAQ), 32.71%
- Jumia Technologies AG (JMIA:NYSE), 30.92%
- Verb Technology Company, Inc. (VERB:NASDAQ), 29.8%